Advances in Biological Chemistry

Advances in Biological Chemistry

ISSN Print: 2162-2183
ISSN Online: 2162-2191
www.scirp.org/journal/abc
E-mail: abc@scirp.org
"Molecular cloning and characterization of human age-related NADH oxidase (arNOX) proteins as members of the TM9 superfamily of transmembrane proteins"
written by Xiaoyu Tang, Debby Parisi, Bradley Spicer, Dorothy M. Morré, D. James Morré,
published by Advances in Biological Chemistry, Vol.3 No.2, 2013
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] TM9SF4 is an F-actin disassembly factor that promotes tumor progression and metastasis
Nature communications, 2022
[2] miR-1193 suppresses the proliferation and invasion of human T-cell leukemia cells through directly targeting the transmembrane 9 superfamily 3 (TM9SF3)
2017
[3] arNOX: A New Source of Aging
Textbook of Aging Skin, 2017
[4] Molecular Cloning and Characterization of a Candidate ENOX Protein of Saccharomyces cerevisiae with a 25 Min Period Insensitive to Simalikalactone D Inhibition and Melatonin
Advances in Biological Chemistry, 2014
[5] Age-Related Surface Oxidases Shed into Body Fluids as Targets to Prevent Skin Aging and Reduce Cardiovascular Risk
World Journal of Cardiovascular Diseases, 2014
[6] Age-related NADH oxidase (arNOX)-catalyzed oxidative damage to skin proteins
Archives of Dermatological Research, 2014
[7] Cloning and Characterization of a Candidate Auxin Plant Growth Regulator-Activated Cell Surface Hydroquinone (NADH) Oxidase
Advances in Biological Chemistry, 2014
[8] Molecular cloning and characterization of a candidate ENOX protein of Saccharomyces cerevisiae with a 25 min period insensitive to simalikalactone D …
2014
[9] Identification of the constitutive ultradian oscillator of the circadian clock (ENOX1) in Saccharomyces cerevisiae
Advances in Biological Chemistry, 2013
[10] Molecular cloning and characterization of an ECTO-NOX3 (ENOX3) of Saccharomyces cerevisiae
2013
[11] Repeated generalized seizures shortly after single intramuscular dose is an additional reasonable cause to restrict the use of ondansetron: A case report
2013
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top